Cargando…

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge

Detalles Bibliográficos
Autor principal: Kim, Hyun Kyung
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023042/
https://www.ncbi.nlm.nih.gov/pubmed/21253418
http://dx.doi.org/10.5045/kjh.2010.45.4.215
_version_ 1782196630775136256
author Kim, Hyun Kyung
author_facet Kim, Hyun Kyung
author_sort Kim, Hyun Kyung
collection PubMed
description
format Text
id pubmed-3023042
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-30230422011-01-20 Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge Kim, Hyun Kyung Korean J Hematol Editorial Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010-12 2010-12-31 /pmc/articles/PMC3023042/ /pubmed/21253418 http://dx.doi.org/10.5045/kjh.2010.45.4.215 Text en © 2010 The Korean Journal of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Kim, Hyun Kyung
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
title Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
title_full Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
title_fullStr Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
title_full_unstemmed Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
title_short Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
title_sort assessment of thrombin-activatable fibrinolysis inhibitor (tafi) activation in acquired hemostatic dysfunction: a diagnostic challenge
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023042/
https://www.ncbi.nlm.nih.gov/pubmed/21253418
http://dx.doi.org/10.5045/kjh.2010.45.4.215
work_keys_str_mv AT kimhyunkyung assessmentofthrombinactivatablefibrinolysisinhibitortafiactivationinacquiredhemostaticdysfunctionadiagnosticchallenge